SCCM is performing maintenance on its websites. For the best browsing experience, please use Microsoft Edge or Safari. Those using Chrome or Firefox may experience access issues at this time.

Tag: Mortality

Tag Search

visual bubble
visual bubble
visual bubble
visual bubble

SCCM Pod-525 PCCM: Extracorporeal Cardiopulmonary Resuscitation Outcomes in Pediatric Patients

Host Marilyn N. Bulloch, PharmD, BCPS, FCCM, is joined by Catherine Beni, MD, PhD, to discuss a study aimed at determining outcomes of extracorporeal CPR (ECPR) in pediatric patients without congenital cardiac disease and identifying associations with in-hospital mortality of factors such as initial arrest rhythm and patient demographics.


SCCM Pod-524 PCCM: Impact of Neighborhood on Pediatric ICU Outcomes

Host Maureen A. Madden, DNP, RN, CPNC-AC, CCRN, FCCM, is joined by Michael C. McCrory, MD, MS, FCCM, to discuss a multicenter retrospective study evaluating the impact of neighborhood, as categorized by the Child Opportunity Index, on pediatric intensive care unit (PICU) outcomes such as mortality, illness severity, and PICU length of stay.


SCCM Pod-521 CCM: Can ICU Liberation Bundle Compliance Impact Post-Intensive Care Syndrome Rates?

Host Kyle B. Enfield, MD, FCCM, is joined by Daisuke Kawakami, MD, to discuss the Critical Care Medicine article, “Evaluation of the Impact of ABCDEF Bundle Compliance Rates on Postintensive Care Syndrome: A Secondary Analysis Study.” The study examines how compliance with the ICU Liberation Bundle (A-F) impacts post-intensive care syndrome and intensive care unit mortality rates.


SCCM Pod-504 CCM: Baricitinib or Tocilizumab for Severe COVID-19

Host Marilyn N. Bulloch, PharmD, BCPS, FCCM, is joined by Joy Peterson, PharmD, BCPS, BCIDP, and Neha Paranjape, MD, MPH, to discuss the Critical Care Medicine article, "Outcomes and Adverse Effects of Baricitinib Versus Tocilizumab in the Management of Severe COVID-19,” which delves into the comparative outcomes, mortality rates, and adverse effects of baricitinib and tocilizumab in severe COVID-19 cases.


SCCM POD-30 CCM: Hospital Mortality Assessment

Jack Zimmerman, MD, FCCM, discusses his article in the May 2006 issue of Critical Care Medicine, "Acute Physiology and Chronic Health Evaluation (or APACHE IV): Hospital Mortality Assessment for Today's Critically Ill Patients."


SCCM Pod-92 Physician Management and Patient Mortality in the ICU

Mitchell Levy, MD, FCCM, discusses his article, "Association between Critical Care Physician Management and Patient Mortality in the Intensive Care Unit," published in the June 3, 2008, issue of Annals of Internal Medicine.


SCCM Pod-94 Increased Mortality of Ventilated Patients with Endotracheal Pseudomonas Aeruginosa

Jeanine Wiener-Kronish, MD, discusses an article published in the September 2008 issue of Critical Care Medicine, titled "Increased Mortality of Ventilated Patients with Endotracheal Pseudomonas Aeruginosa Without Clinical Signs of Infection."


SCCM Pod-147 Daily Predictions of Death in the Medical ICU

William Meadow, MD, PhD, discusses an article published in the March Critical Care Medicine titled, “Power and Limitations of Daily Prognostications of Death in the Medical ICU.”


SCCM Pod-151 Symptoms Experienced by ICU Patients at Risk of Dying

Kathleen A. Puntillo, RN, DNSc, is the lead author of an article published in the November 2010 Critical Care Medicine titled, “Symptoms Experienced by Intensive Care Unit Patients at High Risk of Dying.”


SCCM Pod-220 CCM: Dysglycemia and In-Hospital Mortality in the ICU

Jeffrey Guy, MD, MSc, MMHC, speaks with Omar Badawi, PharmD, MPH, to discuss his article published in the December Critical Care Medicine, “Association Between ICU-Acquired Dysglycemia and In-Hospital Mortality.”


SCCM Pod-246 Interaction Between Fluids and Vasoactive Agents on Mortality in Septic Shock

Todd Fraser, MD, speaks with Allan Garland, MD, about the article, “Interaction Between Fluids and Vasoactive Agents on Mortality in Septic Shock: A Multicenter, Observational Study,” published in Critical Care Medicine.


SCCM Pod-300 Timing of Death in Children Referred for Intensive Care with Severe Sepsis

Margaret Parker, MD, MCCM, speaks with Mirjana Cvetkovic, FRCA, about the article, “Timing of Death in Children Referred for Intensive Care with Severe Sepsis: Implications for Interventional Studies,” published in the June 2015 issue of Pediatric Critical Care Medicine.


SCCM Pod-329 A Bedside Model for Mortality Risk in Pediatric Patients with ARDS

Margaret Parker, MD, MCCM, speaks with Aaron C. Spicer, MD, MAS, about the article, “A Simple and Robust Bedside Model for Mortality Risk in Pediatric Patients With Acute Respiratory Distress Syndrome,” published in the October 2016 issue of Pediatric Critical Care Medicine.


SCCM Pod-362 Time of Admission to the PICU and Mortality

Margaret Parker, MD, MCCM, speaks with Michael C. McCrory, MD, MS, about the article, “Time of Admission to the PICU and Mortality,” published in the October 2017 issue of Pediatric Critical Care Medicine.


SCCM Pod-366 Predictors of In-Hospital Mortality After Rapid Response Team Calls

Dr. Todd Fraser, MD, speaks with Bruce A. Mueller, PharmD, FCCP, FASN, about his talk presented at the 47th Critical Care Congress in San Antonio, Texas, entitled “Artificial Kidney Meets Mechanical Lung: Comanaging the Patient with Renal and Respiratory Failure.”


SCCM Pod-369 Hospital Variation in Risk-Adjusted Pediatric Sepsis Mortality

Margaret Parker, MD, MCCM, speaks with Stefanie G. Ames, MD, about the article “Hospital Variation in Risk-Adjusted Pediatric Sepsis Mortality,” published in the May 2018 issue of Pediatric Critical Care Medicine.


SCCM Pod-439 The Association Between Antibiotic Delay and Hospital Mortality

Explore the correlation between antibiotic delay and hospital mortality in patients with sepsis in this podcast.